The N-terminus of survivin is a mitochondrial-targeting sequence and Src regulator

被引:13
作者
Dunajova, Lucia [1 ]
Cash, Emily [1 ]
Markus, Robert [1 ]
Rochette, Sophie [1 ]
Townley, Amelia R. [1 ]
Wheatley, Sally P. [1 ]
机构
[1] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2UH, England
基金
英国生物技术与生命科学研究理事会;
关键词
Survivin; Src; Mitochondria; Cancer; PROTEIN SURVIVIN; CANCER PATIENTS; NUCLEAR EXPORT; SMAC/DIABLO; EXPRESSION; PROGNOSIS; MECHANISM; APOPTOSIS;
D O I
10.1242/jcs.183277
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Survivin (also known as BIRC5) is a cancer-associated protein that exists in several locations in the cell. Its cytoplasmic residence in interphase cells is governed by CRM1 (also known as XPO1)-mediated nuclear exportation, and its localisation during mitosis to the centromeres and midzone microtubules is that of a canonical chromosomal passenger protein. In addition to these well-established locations, survivin is also a mitochondrial protein, but how it gets there and its function therein is presently unclear. Here, we show that the first ten amino acids at the N-terminus of survivin are sufficient to target GFP to the mitochondria in vivo, and ectopic expression of this decapeptide decreases cell adhesion and accelerates proliferation. The data support a signalling mechanism in which this decapeptide regulates the tyrosine kinase Src, leading to reduced focal adhesion plaques and disruption of F-actin organisation. This strongly suggests that the N-terminus of survivin is a mitochondrial-targeting sequence that regulates Src, and that survivin acts in concert with Src to promote tumorigenesis.
引用
收藏
页码:2707 / 2712
页数:6
相关论文
共 25 条
  • [1] Opinion - Survivin, cancer networks and pathway-directed drug discovery
    Altieri, Dario C.
    [J]. NATURE REVIEWS CANCER, 2008, 8 (01) : 61 - 70
  • [2] Regulation of mitochondrial Smac/DIABLO-selective release by survivin
    Ceballos-Cancino, G.
    Espinosa, M.
    Maldonado, V.
    Melendez-Zajgla, J.
    [J]. ONCOGENE, 2007, 26 (54) : 7569 - 7575
  • [3] Separating the anti-apoptotic and mitotic roles of survivin
    Colnaghi, Rita
    Connell, Claire M.
    Barrett, Rachel M. A.
    Wheatley, Sally P.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) : 33450 - 33456
  • [4] Nuclear survivin has reduced stability and is not cytoprotective
    Connell, Claire M.
    Colnaghi, Rita
    Wheatley, Sally P.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (06) : 3289 - 3296
  • [5] Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
    Dohi, T
    Beltrami, E
    Wall, NR
    Plescia, J
    Altieri, DC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08) : 1117 - 1127
  • [6] Regulation of survivin function by Hsp90
    Fortugno, P
    Beltrami, E
    Plescia, J
    Fontana, J
    Pradhan, D
    Marchisio, PC
    Sessa, WC
    Altieri, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) : 13791 - 13796
  • [7] Src in cancer: deregulation and consequences for cell behaviour
    Frame, MC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (02): : 114 - 130
  • [8] Src as a potential therapeutic target in non-small-cell lung cancer
    Giaccone, G.
    Zucali, P. A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (07) : 1219 - 1223
  • [9] BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery
    Hagenbuchner, J.
    Kuznetsov, A. V.
    Obexer, P.
    Ausserlechner, M. J.
    [J]. ONCOGENE, 2013, 32 (40) : 4748 - 4757
  • [10] Mitochondrial Heat Shock Protein-90 Modulates Vascular Smooth Muscle Cell Survival and the Vascular Injury Response in Vivo
    Hoel, Andrew W.
    Yu, Peng
    Nguyen, Khanh P.
    Sui, Xinxin
    Plescia, Janet
    Altieri, Dario C.
    Conte, Michael S.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (04) : 1151 - 1157